AIM ImmunoTech Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	0.03M	0.05M	0.03M	0.03M	0.02M	0.06M	0.05M	0.04M	0.05M	0.07M	0.04M	0.05M	0.04M	0.04M	0.02M	0.03M	0.03M	0.02M	0.02M	0.03M
Cost of Revenue (Quarter)	0.16M	0.18M	0.08M	0.07M					0.03M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.07M	0.04M	0.00M	0.01M
Gross Profit (Quarter)	-0.12M	-0.13M	-0.04M	-0.04M					0.02M	0.05M	0.03M	0.04M	0.03M	0.04M	0.01M	0.01M	-0.04M	-0.02M	0.02M	0.02M
Operating items
Research & Development (Quarter)	2.01M	2.34M	1.04M	2.48M	6.40M	0.20M	2.05M	2.95M	2.73M	3.20M	1.95M	1.15M	1.44M	1.66M	1.08M	1.17M	0.61M	1.06M	0.48M	0.59M
Selling, General & Administrative (Quarter)	1.80M	2.62M	2.07M	2.18M	5.17M	3.50M	2.29M	2.55M	5.44M	10.86M	3.81M	2.59M	3.08M	4.23M	2.54M	1.49M	1.80M	1.87M	1.76M	2.94M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)			0.08M	0.07M	-5.03M	1.91M	-0.02M		0.04M	0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.07M	0.04M	0.00M	0.01M
Operating Expenses (Quarter)	3.96M	7.50M	3.19M	4.72M	6.54M	5.61M	4.34M	5.50M	8.20M	14.07M	5.77M	3.74M	4.52M	5.90M	3.63M	2.67M	2.47M	2.97M	2.25M	3.54M
Operating Income (Quarter)	-3.93M	-7.45M	-3.15M	-4.70M	-6.52M	-5.56M	-4.29M	-5.46M	-8.16M	-14.00M	-5.73M	-3.69M	-4.49M	-5.86M	-3.62M	-2.65M	-2.45M	-2.95M	-2.23M	-3.51M
EBIT (Quarter)	-3.93M	-7.45M	-3.15M	-4.70M	-6.52M	-5.56M	-4.29M	-5.46M	-8.16M	-14.00M	-5.73M	-3.69M	-4.49M	-5.86M	-3.62M	-2.65M	-2.45M	-2.95M	-2.23M	-3.51M
Non-operating items
Non Operating Interest Expenses (Quarter)
Non Operating Investment Income (Quarter)			-0.93M	-0.47M	-0.36M	0.09M	0.20M	-0.09M	-0.31M	0.40M	-0.09M	-0.09M	0.27M	-0.19M	0.03M	-0.01M	-0.00M		-0.00M	-0.00M
Interest & Investment Income (Quarter)	-0.02M		0.04M	0.08M
Other Non Operating Income (Quarter)	-0.02M	-2.80M	0.04M	0.08M	0.17M	0.33M	0.20M	0.32M	0.29M	0.26M	0.08M	-0.46M	0.72M	5.65M	0.01M	0.01M	-3.98M	7.16M	0.01M	0.02M
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	-5.07M	-7.45M	-3.34M	-4.86M	-6.76M	-5.63M	-4.50M	-5.66M	-8.36M	-14.14M	-8.31M	-6.33M	-4.71M	-5.99M	-3.81M	-4.94M	-2.63M	-3.23M	-3.22M	-7.13M
Profit After Tax (Quarter)	-3.83M	-5.64M	-3.82M	-4.85M	-6.38M	-4.39M	-3.66M	-4.91M	-7.82M	-12.58M	-5.82M	-1.84M	-3.70M	-5.97M	-3.71M	-2.79M	-3.28M	-4.17M	-3.02M	-3.79M
Income from Non-Controlling Interests (Quarter)	-0.10M
Income from Continuing Operations (Quarter)	-5.07M	-7.45M	-3.34M	-4.86M	-6.76M	-5.63M	-4.50M	-5.66M	-8.36M	-14.14M	-8.31M	-6.33M	-4.71M	-5.99M	-3.81M	-4.94M	-2.63M	-3.23M	-3.22M	-7.13M
Consolidated Net Income (Quarter)	-5.07M	-7.45M	-3.34M	-4.86M	-6.76M	-5.63M	-4.50M	-5.66M	-8.36M	-14.14M	-8.31M	-6.33M	-4.71M	-5.99M	-3.81M	-4.94M	-2.63M	-3.23M	-3.22M	-7.13M
Income towards Parent Company (Quarter)	-5.07M	-7.45M	-3.34M	-4.86M	-6.76M	-5.63M	-4.50M	-5.66M	-8.36M	-14.14M	-8.31M	-6.33M	-4.71M	-5.99M	-3.81M	-4.94M	-2.63M	-3.23M	-3.22M	-7.13M
Net Income towards Common Stockholders (Quarter)	-5.07M	-7.45M	-3.34M	-4.86M	-6.76M	-5.63M	-4.50M	-5.66M	-8.36M	-14.14M	-8.31M	-6.33M	-4.71M	-5.99M	-3.81M	-4.94M	-2.63M	-3.23M	-3.22M	-7.13M
Additional items
EPS (Basic) (Quarter)	-0.01	-15.73	-6.96	-10.11	-14.05	-11.72	-9.29	-11.69	-17.18	-29.11	-16.80	-11.98	-8.16	-10.69	-5.42	-6.50	-1.26	-2.00	-0.74	-0.42
EPS (Diluted) (Quarter)				-10.11	-14.05	-11.72	-9.29	-11.69	-17.18	-29.11	-16.80	-11.98	-8.16	-10.69	-5.42	-6.50	-1.26	-2.00	-0.74	-0.42
Shares Outstanding (Quarter)	478.46M	0.47M	0.48M	0.48M	0.48M	0.48M	0.48M	0.48M	0.49M	0.49M	0.49M	0.53M	0.58M	0.56M	0.70M	0.76M	2.09M	1.62M	4.35M	17.12M
Shares Outstanding (Diluted) (Quarter)				0.48M	0.48M	0.48M	0.48M	0.48M	0.49M	0.49M	0.49M	0.53M	0.58M	0.56M	0.70M	0.76M	2.09M	1.62M	4.35M	17.12M
Shares Outstanding (Entity) (Quarter)	478.46M	0.48M	0.48M	0.48M	0.48M	0.48M	0.48M	0.48M	0.49M	0.49M	0.50M	0.57M	0.59M	0.66M	0.72M	0.76M	2.09M	1.62M	4.35M	17.12M
EBITDA (Quarter)	-3.93M	-7.45M	-3.15M	-4.70M	-6.52M	-5.56M	-4.29M	-5.46M	-8.16M	-14.00M	-5.73M	-3.69M	-4.49M	-5.86M	-3.62M	-2.65M	-2.45M	-2.95M	-2.23M	-3.51M
Interest Expenses (Quarter)	1.12M		0.23M	0.24M	0.23M	0.08M	0.20M	0.20M	0.20M	0.14M	2.57M	2.64M	0.22M	0.13M	0.20M	2.29M	0.19M	0.28M	1.00M	3.62M

Research Tools

Datasets

Plans

Developers

AIM ImmunoTech AIM Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

AIM ImmunoTech AIM Income Statement (2010-2026)

Create an account

Sign In

Reset Password